Matsumura et al. analyzed 65 patients with R/M-HNSCC and found that in univariable analysis, NLR, PLR, and SII were significant negative predictors of PFS and OS during anti-PD-1 immunotherapy. Here, PDCD1 is linked to head and neck squamous cell carcinoma.